96 related articles for article (PubMed ID: 28579428)
41. Biochanin A inhibits lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
Ming X; Ding M; Zhai B; Xiao L; Piao T; Liu M
Life Sci; 2015 Sep; 136():36-41. PubMed ID: 26141992
[TBL] [Abstract][Full Text] [Related]
42. Involvement of nuclear receptor RZR/RORγ in melatonin-induced HIF-1α inactivation in SGC-7901 human gastric cancer cells.
Wang RX; Liu H; Xu L; Zhang H; Zhou RX
Oncol Rep; 2015 Nov; 34(5):2541-6. PubMed ID: 26330273
[TBL] [Abstract][Full Text] [Related]
43. Targeted Inhibition of the NCOA1/STAT6 Protein-Protein Interaction.
Lee Y; Yoon H; Hwang SM; Shin MK; Lee JH; Oh M; Im SH; Song J; Lim HS
J Am Chem Soc; 2017 Nov; 139(45):16056-16059. PubMed ID: 29090910
[TBL] [Abstract][Full Text] [Related]
44. Retinoid acid-related orphan receptor γ, RORγ, participates in diurnal transcriptional regulation of lipid metabolic genes.
Takeda Y; Kang HS; Lih FB; Jiang H; Blaner WS; Jetten AM
Nucleic Acids Res; 2014; 42(16):10448-59. PubMed ID: 25143535
[TBL] [Abstract][Full Text] [Related]
45. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
46. Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
Marcotte DJ; Liu Y; Little K; Jones JH; Powell NA; Wildes CP; Silvian LF; Chodaparambil JV
BMC Struct Biol; 2016 Jun; 16(1):7. PubMed ID: 27246200
[TBL] [Abstract][Full Text] [Related]
47. Differential and day-time dependent expression of nuclear receptors RORα, RORβ, RORγ and RXRα in the rodent pancreas and islet.
Mühlbauer E; Bazwinsky-Wutschke I; Wolgast S; Labucay K; Peschke E
Mol Cell Endocrinol; 2013 Jan; 365(2):129-38. PubMed ID: 23073388
[TBL] [Abstract][Full Text] [Related]
48. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
49. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis.
Latourte A; Cherifi C; Maillet J; Ea HK; Bouaziz W; Funck-Brentano T; Cohen-Solal M; Hay E; Richette P
Ann Rheum Dis; 2017 Apr; 76(4):748-755. PubMed ID: 27789465
[TBL] [Abstract][Full Text] [Related]
50. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
[TBL] [Abstract][Full Text] [Related]
51. High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma.
Ueda E; Kurebayashi S; Sakaue M; Backlund M; Koller B; Jetten AM
Cancer Res; 2002 Feb; 62(3):901-9. PubMed ID: 11830550
[TBL] [Abstract][Full Text] [Related]
52. Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds.
Zhang W; Zhang J; Fang L; Zhou L; Wang S; Xiang Z; Li Y; Wisely B; Zhang G; An G; Wang Y; Leung S; Zhong Z
Mol Pharmacol; 2012 Oct; 82(4):583-90. PubMed ID: 22700697
[TBL] [Abstract][Full Text] [Related]
53. An inhibitor of RORγ for chronic pulmonary obstructive disease treatment.
Desai H; Marathe M; Potdar V; Tiwari P; Joshi A; Kadam SR; Joshi AR; Kulkarni A; Bhosale V; Hadambar A; Lodhiya B; Udupa V; Behera D; Chaudhari SS; Das S; Bajpai M; Gowda N; Iyer PS
Sci Rep; 2022 May; 12(1):8744. PubMed ID: 35610240
[TBL] [Abstract][Full Text] [Related]
54. RORγ Structural Plasticity and Druggability.
Huang M; Bolin S; Miller H; Ng HL
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727079
[TBL] [Abstract][Full Text] [Related]
55. Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction.
Noguchi M; Nomura A; Doi S; Yamaguchi K; Hirata K; Shiozaki M; Maeda K; Hirashima S; Kotoku M; Yamaguchi T; Katsuda Y; Crowe P; Tao H; Thacher S; Adachi T
Sci Rep; 2018 Nov; 8(1):17374. PubMed ID: 30478402
[TBL] [Abstract][Full Text] [Related]
56. Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer.
Aicher TD; Van Huis CA; Hurd AR; Skalitzky DJ; Taylor CB; Beleh OM; Glick G; Toogood PL; Yang B; Zheng T; Huo C; Gao J; Qiao C; Tian X; Zhang J; Demock K; Hao LY; Lesch CA; Morgan RW; Moisan J; Wang Y; Scatina J; Paulos CM; Zou W; Carter LL; Hu X
J Med Chem; 2021 Sep; 64(18):13410-13428. PubMed ID: 34499493
[TBL] [Abstract][Full Text] [Related]
57. Insight into the molecular recognition mechanism of the coactivator NCoA1 by STAT6.
Russo L; Giller K; Pfitzner E; Griesinger C; Becker S
Sci Rep; 2017 Dec; 7(1):16845. PubMed ID: 29203888
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs).
Nefzi A; Marconi GD; Ortiz MA; Davis JC; Piedrafita FJ
Bioorg Med Chem Lett; 2017 Apr; 27(7):1608-1610. PubMed ID: 28242276
[TBL] [Abstract][Full Text] [Related]
59. Ginseng-derived panaxadiol ameliorates STZ-induced type 1 diabetes through inhibiting RORγ/IL-17A axis.
Tian SY; Chen SM; Feng YY; He JL; Li Y
Acta Pharmacol Sin; 2023 Jun; 44(6):1217-1226. PubMed ID: 36650291
[TBL] [Abstract][Full Text] [Related]
60. Discovery of biaryls as RORγ inverse agonists by using structure-based design.
Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD
Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
